The director of Royan Umbilical Cord Blood Bank in Kurdistan stated that umbilical cord blood from newborns can be stored starting from the thirty-fourth week of pregnancy. He noted that stem cells present in umbilical cord blood are used in the treatment of over 80 diseases, including certain blood cancers, blood disorders, and immune system deficiencies.
Umbilical Cord Blood Used in Treatment of Over 80 Blood and Non-Blood Diseases
The Royan Umbilical Cord Blood Bank in Kurdistan announced that stem cells from umbilical cord blood can treat over 80 diseases, including blood cancers and immune disorders. Storage of cord blood is possible from the 34th week of pregnancy onward. This highlights Iran's advancement in regenerative medicine and stem cell research.
👥 Key Players
📰 What Happened
The Royan Umbilical Cord Blood Bank announced that stem cells from newborn umbilical cord blood can be stored from the 34th week of pregnancy and used to treat over 80 diseases. These diseases include blood cancers, blood disorders, and immune system deficiencies. The announcement highlights Iran's capabilities in regenerative medicine and stem cell therapy.
- Cord blood can be stored starting at 34 weeks of pregnancy
- Stem cells from cord blood treat over 80 diseases
- Treatable conditions include blood cancers, blood disorders, and immune deficiencies
💡 Why It Matters
📚 Background
Umbilical cord blood contains hematopoietic stem cells that can develop into blood and immune cells, making them valuable for treating blood disorders and cancers. Stem cell research is a global priority in regenerative medicine, though Iran's program has developed somewhat independently due to international sanctions limiting collaboration.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 90%